Thrombocythemia or polycythemia vera and primary or secondary myelofibrosis
increased the number of EPCs in patients with heart failure compared with healthy controls. Atorvastatin therapy increased the migration and adhesion of EPCs in patients with chronic pulmonary heart disease.…